---
title: "Jigar Cables Ltd (540651) — Share Price, Financials & Analysis"
symbol: "540651"
company: "Jigar Cables Ltd"
canonical: "https://tapetide.com/stocks/540651"
isin: "INE943X01015"
nse_symbol: "JIGARCABLESLTD"
bse_code: "540651"
sector: "Capital Goods"
industry: "Other Electrical Equipment"
market_cap_cr: 54.9
generated_at: "2026-09-13T19:38:48.192Z"
---

# Jigar Cables Ltd (540651)

Canonical page: https://tapetide.com/stocks/540651

## Company

- **NSE Symbol:** JIGARCABLESLTD
- **BSE Code:** 540651
- **ISIN:** INE943X01015
- **Sector:** Capital Goods
- **Industry:** Other Electrical Equipment
- **Macro Sector:** Industrials
- **Stock Type:** EQUITY
- **Listed Since:** 2017-07-28
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** sigmacab.com

## About

Incorporated in 2017, Jigar Cables Ltd manufactures Electric wires, cables, and 
PVC.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:40:00.938886Z.

- **Market Cap:** ₹54.9 Cr
- **Classification:** SME
- **P/E (reported):** 30.5
- **EPS (reported):** ₹1.48
- **Book Value:** ₹33.62
- **Price to Book:** 1.81
- **Dividend Yield:** 0%
- **ROE:** 5.94%
- **ROCE:** 7.76%
- **Debt to Equity:** 0.39
- **Revenue (yearly):** ₹58.2 Cr
- **Net Income:** ₹1.8 Cr
- **EBITDA:** ₹3.6 Cr
- **52-Week High:** ₹76.9
- **52-Week Low:** ₹50
- **RSI (14):** 20.61

## Key Insights

### Strengths

- Debtor days have improved from 40.1 to 19.6 days.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.38% over last 3 years.
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -120.97% | -48.96% | -350.88% |
| ebitda margin growth | 41.71% | 20.12% | -44.54% |
| net income growth | 0% | 20% | 34% |
| revenue growth | -44.68% | 27% | 32% |
| roce | -58.19% | -16.74% | 10.46% |
| roe | -31.49% | 6.68% | 156.03% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6.78 | 7.64 | 6.2 | 6.45 | 12.49 | 15.96 | 16.41 | 26.22 | 61.72 | 43.39 | 26.23 | 31.72 |
| Expenses | 6.59 | 7.1 | 5.72 | 5.86 | 11.7 | 14.63 | 15.54 | 25.12 | 59.45 | 41.2 | 24.81 | 29.8 |
| Operating Profit | 0.19 | 0.54 | 0.48 | 0.59 | 0.79 | 1.33 | 0.87 | 1.1 | 2.27 | 2.19 | 1.42 | 1.92 |
| OPM % | 2.8 | 7.07 | 7.74 | 9.15 | 6.33 | 8.33 | 5.3 | 4.2 | 3.68 | 5.05 | 5.41 | 6.05 |
| Other Income | 0.6 | 0.13 | 0.22 | 0.1 | 0.07 | 0.06 | 0.02 | 0.2 | 0.01 | 0.1 | 0.06 | 0.18 |
| Interest | 0.25 | 0.1 | 0.22 | 0.21 | 0.23 | 0.17 | 0.2 | 0.14 | 0.9 | 0.63 | 0.19 | 0.25 |
| Depreciation | 0.29 | 0.28 | 0.26 | 0.26 | 0.22 | 0.23 | 0.2 | 0.2 | 0.18 | 0.38 | 0.52 | 0.23 |
| Profit before tax | 0.25 | 0.29 | 0.22 | 0.22 | 0.41 | 0.99 | 0.49 | 0.96 | 1.2 | 1.28 | 0.77 | 1.62 |
| Tax % | 8 | 34.48 | 18.18 | 22.73 | 19.51 | 29.29 | 26.53 | 28.12 | 25 | 28.12 | 24.68 | 25.31 |
| Net Profit | 0.22 | 0.2 | 0.17 | 0.17 | 0.33 | 0.7 | 0.36 | 0.68 | 0.89 | 0.93 | 0.59 | 1.21 |
| EPS in Rs | 0.31 | 0.28 | 0.24 | 0.24 | 0.47 | 1 | 0.51 | 0.97 | 1.27 | 1.32 | 0.65 | 1.34 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 19.72 | 21.39 | 13.59 | 14.25 | 11.96 | 28.46 | 42.49 | 104.83 | 57.94 |
| Expenses | 18.23 | 19.98 | 12.44 | 13.51 | 10.9 | 26.34 | 40.51 | 100.38 | 54.6 |
| Operating Profit | 1.49 | 1.41 | 1.15 | 0.74 | 1.06 | 2.12 | 1.98 | 4.45 | 3.34 |
| OPM % | 7.56 | 6.59 | 8.46 | 5.19 | 8.86 | 7.45 | 4.66 | 4.24 | 5.76 |
| Other Income | 0.09 | 0.48 | 0.45 | 0.73 | 0.3 | 0.13 | 0.22 | 0.11 | 0.24 |
| Interest | 0.56 | 0.5 | 0.51 | 0.36 | 0.41 | 0.4 | 0.35 | 1.52 | 0.44 |
| Depreciation | 0.54 | 0.73 | 0.63 | 0.56 | 0.53 | 0.45 | 0.4 | 0.56 | 0.75 |
| Profit before tax | 0.48 | 0.66 | 0.46 | 0.55 | 0.42 | 1.4 | 1.45 | 2.48 | 2.39 |
| Tax % | 16.67 | 27.27 | 45.65 | 21.82 | 19.05 | 26.43 | 28.28 | 26.61 | 24.69 |
| Net Profit | 0.4 | 0.48 | 0.25 | 0.42 | 0.34 | 1.03 | 1.04 | 1.82 | 1.8 |
| EPS in Rs | 0.57 | 0.68 | 0.36 | 0.6 | 0.48 | 1.46 | 1.48 | 2.59 | 2 |
| Dividend Payout % | 0 | 29.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 9.01 |
| Reserves | 6.29 | 6.6 | 6.84 | 7.26 | 7.6 | 8.63 | 12.16 | 13.98 | 21.28 |
| Borrowings | 4.36 | 4.31 | 4.14 | 4.79 | 4.41 | 5.64 | 4.89 | 2.83 | 11.93 |
| Other Liabilities | 0.59 | 8.71 | 5.01 | 1.02 | 1.29 | 2.01 | 1.29 | 1.33 | 3.34 |
| Total Liabilities | 18.27 | 26.65 | 23.02 | 20.1 | 20.33 | 23.31 | 25.37 | 25.17 | 45.56 |
| Fixed Assets | 3.77 | 4.79 | 4.12 | 4.06 | 3.68 | 3.31 | 3.13 | 5.09 | 4.72 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.43 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 14.5 | 21.86 | 18.9 | 16.04 | 16.65 | 20 | 22.24 | 20.08 | 26.41 |
| Total Assets | 18.27 | 26.65 | 23.02 | 20.1 | 20.33 | 23.31 | 25.37 | 25.17 | 45.56 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -2.78 | 3.25 | -0.29 | 0.12 | 0.57 | -0.06 | -0.96 | 6.82 | -1.43 |
| Cash from Investing Activity | -5.82 | -2.68 | 0.64 | -0.09 | 0.23 | -0.63 | -0.41 | -2.23 | -14.78 |
| Cash from Financing Activity | 8.29 | -0.53 | -0.92 | 0.2 | -0.79 | 0.84 | 1.4 | -3.55 | 16.1 |
| Net Cash Flow | -0.31 | 0.04 | -0.57 | 0.23 | 0.02 | 0.15 | 0.04 | 1.03 | -0.12 |
| Free Cash Flow | -5.73 | 1.5 | -0.24 | -0.38 | 0.41 | -0.13 | -1.39 | 4.52 | -16.24 |
| CFO/OP | -182 | 232 | -9 | 35 | 68 | 15 | -28 | 164 | -28 |

### Ratios

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 18.69 | 105.11 | 173.5 | 64.8 | 103.15 | 86.31 | 67.95 | 32.69 | 19.65 |
| Inventory Days | 133.18 | 81.91 | 231.29 | 247.26 | 354.81 | 172.03 | 124.01 | 31.59 | 119.79 |
| Days Payable | 8.41 | 45.16 | 164.61 | 23.23 | 34.89 | 23.7 | 7.63 | 1.5 | 15.38 |
| Cash Conversion Cycle | 143.47 | 141.86 | 240.18 | 288.83 | 423.07 | 234.64 | 184.33 | 62.79 | 124.07 |
| Working Capital Days | 111.05 | 81.74 | 164.64 | 171.1 | 246.89 | 151.98 | 129.63 | 50.73 | 96.45 |
| ROCE % | — | 6.4 | 5.34 | 4.91 | 4.35 | 8.92 | 7.93 | 16.69 | 8.57 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 44.48% | 44.48% | 44.48% | 44.48% | 44.48% | 44.48% | 44.48% | 44.48% | 44.48% | 42.48% | 42.48% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 53.53% | 53.53% | 53.41% | 40.24% | 39.96% | 40.13% | 37.41% | 36.93% | 37.1% | 35.59% | 35.54% |
| Others | 1.99% | 1.99% | 2.1% | 15.27% | 15.56% | 15.39% | 18.1% | 18.59% | 18.42% | 21.94% | 21.98% |
| No. of Shareholders | 184 | 176 | 173 | 171 | 170 | 187 | 166 | 168 | 177 | 179 | 184 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 62.72 | Sell |
| EMA (10) | 61.32 | Sell |
| SMA (20) | 63.12 | Sell |
| EMA (20) | 62.55 | Sell |
| SMA (50) | 64.3 | Sell |
| EMA (50) | 63.79 | Sell |
| SMA (100) | 62.96 | Sell |
| EMA (100) | 64.67 | Sell |
| SMA (200) | 67.36 | Sell |
| EMA (200) | 62.54 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.47 | Neutral |
| MACD (12,26,9) | -1.24 | Sell |
| Stochastic (14,3,3) | 36.2 | Neutral |
| ADX (14) | 15.4 | Neutral |
| Williams %R (14) | -57.42 | Neutral |
| ATR (14) | 6.9 | High Volatility |
| ROC (12) | -10.52 | Sell |
| Stoch RSI (14) | 34.55 | Neutral |
| UO (7,14,28) | 61.99 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a04606a5-7766-4fda-9015-030fddee311f.pdf) |
| 2026-09-01 | [Notice Of 10Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9eaa8269-728f-4d12-b512-a638abade617.pdf) |
| 2026-09-01 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d12ef47-6b67-4f2c-b1f7-7acb5f83e528.pdf) |
| 2026-08-24 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On August 24 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f434cb5-04be-40e3-abe6-1327c984ee66.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc585435-bb08-4286-be53-839e941dbe43.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=465f7b2f-7429-41de-8a97-8a02845df3ed.pdf) |
| 2026-07-08 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=285e29c1-db7e-4a42-a145-2b279a53588a.pdf) |
| 2026-05-23 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cbeb191-8803-4a1b-a8d4-1f985622a408.pdf) |
| 2026-05-23 | [Announcement Under Regulation 30 Of SEBI LODR - Update On Commencement Of Commercial Production At New Manufacturing Facility](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f38da37c-5e23-41a5-af22-2b47c124b5dc.pdf) |
| 2026-05-21 | [Board Meeting Outcome for The Meeting Of The Board Of Directors Held On May 21 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d755dfb8-916c-4e7e-b44d-9bc85c07e1e5.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-21 | [Results - Financial Results For The Half Year And Financial Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4321ed22-db7f-4e2d-a57e-af0c98d87116.pdf) |
| 2025-11-12 | [Results - Financial Results For The Half Year Ended On September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1267c894-c0b9-4300-bd17-f4b65fcbb37a.pdf) |
| 2025-05-22 | [Outcome Of Board Meeting - Audited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c931d2-2ce3-4c1d-b452-7a76492c82fd.pdf) |
| 2024-11-11 | [Outcome Of Board Meeting - Half Yearly Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18daefd8-7d32-41ba-afdc-447f50397857.pdf) |
| 2024-05-23 | [Results - Audited Financial Results For March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5324a1d7-83f4-4e71-9eea-0663586ecc30.pdf) |
| 2023-10-31 | [Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Half Year Ended On September 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e05763ad-8e31-4bc1-a2b8-b0d6233667a6.pdf) |
| 2023-10-31 | [Results - Unaudited Financial Results For September 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6d67f93-441a-4c1c-8142-814c6f144010.pdf) |
| 2023-05-23 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7264558-c827-44d6-8d52-f8228a885201.pdf) |
| 2023-05-23 | [Audited Standalone And Consolidated Financial Results For The Half Year And Year Ended March 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9f203cf-5884-4f3c-ad08-3ca05e21b84d.pdf) |
| 2022-11-09 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02304321-a0d5-4887-a7da-ab31fdb98e93.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Jan - Copies of the newspaper advertisement published pursuant to the Postal Ballot Notice. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Jan - Copies of the newspaper advertisement published pursuant to the Postal Ballot Notice.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bfcd9cd-bd9c-4a35-a3f6-df60a6c7f751.pdf) |
| 9 Jan - Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018, for the quarter ended on December 31, 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan - Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018, for the quarter ended on December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f60f2e2-bad2-4d0a-85ba-e2c463e54a12.pdf) |
| 7 Dec 2024 - Post-facto intimation of CoC meeting held. | [Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors 7 Dec 2024 - Post-facto intimation of CoC meeting held.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0d899a10-7ec1-484b-9e6f-220748b29dd3.pdf) |
| 6 Apr - Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8ef3a237-da79-4d45-bf01-1f00e58232a6.pdf) |
| 5 Dec 2024 - Meeting of Committee of Creditors scheduled for December 5, 2024. | [Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors 5 Dec 2024 - Meeting of Committee of Creditors scheduled for December 5, 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b792d62c-610d-4731-9a4c-20157e68c0b5.pdf) |
| 30 Mar - Commercial production of conductors began March 30, 2026; full-scale MVCC/HT production expected in 2–3 months. | [Announcement Under Regulation 30 Of SEBI LODR - Update On Commencement Of Commercial Prodution. 30 Mar - Commercial production of conductors began March 30, 2026; full-scale MVCC/HT production expected in 2–3 months.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/304201fa-9d17-442e-ab58-d9df445bbd27.pdf) |
| 23 Mar - Trading window closed from April 1, 2026; reopens 48 hours after audited results for quarter/year ending March 31, 2026. | [Closure of Trading Window 23 Mar - Trading window closed from April 1, 2026; reopens 48 hours after audited results for quarter/year ending March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9dc89f59-e472-409a-af55-6782c6bae983.pdf) |
| 23 Jan 2025 - NCLT approved resolution plan for Parenteral Drugs (India) Ltd. | [Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal 23 Jan 2025 - NCLT approved resolution plan for Parenteral Drugs (India) Ltd.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be4b45c6-889d-41a7-9f03-1e1128c188c3.pdf) |
| 22 Jan 2025 - NCLT approves resolution plan for Parenteral Drugs. | [Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal 22 Jan 2025 - NCLT approves resolution plan for Parenteral Drugs.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a72814a8-8c16-4164-bf5d-736c5123020a.pdf) |
| 16h - Board meeting on May 21, 2026 to approve audited H1 and FY2026 financial results; trading window closed from April 1. | [Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Stanalone And Consolidated) For The Half Year And Financial Year Ended On March 31, 2026. 16h - Board meeting on May 21, 2026 to approve audited H1 and FY2026 financial results; trading window closed from April 1.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/904ce1c5-9ef0-47ef-beae-e86c346d8c7e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1551_PDPL_2012_2013_10092013115256.zip) |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_PDPL_2010_2011_08092011043838.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aea4df67-0727-457e-9bcc-6372aaed25bc.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/52d55828-f012-439d-a35a-baf362eaef52.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6202d7f3-bb68-496a-a013-6dff36759bbe.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/540651/75331540651.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/540651/70103540651.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524689/70477524689.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/540651/66441540651.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524689/65124524689.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:38:48.192Z.